
RADIOPHOTONICS LAB
The Radiophotonics Lab was founded in 2023 by Dr. Deepak Dinakaran at the Sunnybrook Research Institute. The lab’s research originates from the discovery of a polymeric nanoparticle designed to be activated by radiotherapy for anti-cancer therapy.
This nanoparticle platform is unique in that it is engineered to be as inert and non-toxic as possible until sufficient radiation energy is delivered to its location. Upon activation, the nanoparticles generate highly reactive oxyradicals that locally damage tumor cells, enhancing therapeutic efficacy beyond radiation alone.
The lab integrates nanotechnology, radiation oncology, photochemistry, and molecular biology to develop next-generation cancer therapies with improved precision and reduced systemic toxicity.

Our Research
Our research bridges radiation oncology, nanomedicine, and photodynamic therapy to develop innovative strategies for cancer treatment, with a particular focus on glioblastoma. We investigate how radiation-activated nanoparticles can modulate the tumor microenvironment, enhance immune priming, and enable precise, image-guided therapeutic interventions.




